Glutamate excitotoxicity in a model of multiple sclerosis

Nature Medicine

Volumn 6, Issue 1, 2000, Pages 67-70

  Pitt, David ^a   Werner, Peter ^a   Raine, Cedric S ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID RECEPTOR ANTAGONIST; MYELIN;

ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; DEMYELINATION; IMMUNOCOMPETENT CELL; INFLAMMATION; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NEUROTOXICITY; OLIGODENDROGLIA; PRIORITY JOURNAL;

ANIMALS; AXONS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MULTIPLE SCLEROSIS; QUINOXALINES; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; T-LYMPHOCYTES;

ANIMALIA;

EID: 0033958462     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/71555     Document Type: Article

References (22)

1. McDonald, J.W., Althomsons, S.P., Hyrc, K.L., Choi, D. & Goldberg, M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nature Med. 4, 291-297 (1998).
2. Prineas, J.W. & McDonald, I. in Greenfield's Neuropathology (eds. Graham D.I. & Lantos P.L.) 813-881 (Arnold, New York, 1997).
3. Piani, D., Frei, K., Do, K.Q., Cuénod, M. & Fontana, A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133, 159-162 (1991).
4. Trapp, B.D. et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278-285 (1998).
5. Yoshioka, A., Bacskai, B. & Pleasure, D. Pathophysiology of oligodendroglial excitotoxicity. J. Neurosci. Res. 46, 427-37 (1996).
6. Cannella, B. et al. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc. Natl. Acad. Sci. USA 95, 10100-10105 (1998).
7. Raine, C.S. in Multiple Sclerosis Clinical and Pathogenetic Basis (eds. Raine, C.S., McFarland, H.F. & Tourtellotte, W.W.) 243-286 (Chapman & Hall, London, 1997).
8. Szaro, B.G., Whitnall, M.H. & Gainer, H. Phosphorylation-dependent epitopes on neurofilament proteins and neurofilament densities differ in axons in the corticospinal and primary sensory dorsal column tracts in the rat spinal cord. J. Comp. Neurol. 302, 220-235 (1990).
9. Rodriguez-Moreno, A., Herreras, O. & Lerma, J. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus. Neuron 19, 893-901 (1997).
10. Selmaj, K.W. & Raine, C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346 (1988).
11. Gijbels, K., Galardy, R.E. & Steinman, L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94, 2177-2182 (1994).
12. Ding, M. et al. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160, 2560-2564 (1998).
13. Genain, C.P., Cannella, B., Hauser, S.L. & Raine, C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med. 5, 170-175 (1999).
14. Hardin-Pouzet, H. et al. Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis. Glia 20, 79-85 (1997).
15. Buryakova, A.V. & Sytinsky, I.A. Amino acid composition of cerebrospinal fluid in acute neuroinfections in children. Arch. Neurol. 32, 28-31 (1975).
16. Stover, J.F. et al. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur. J. Clin. Invest. 27, 1038-43 (1997).
17. Rothman, S.M. & Olney, J.W. Excitotoxicity and the NMDA receptor. Trends Neurosci. 10, 299-302 (1987).
18. Collins, R.C., Dobkin, B.H. & Choi, D.W. Selective vulnerability of the brain: new insights into the pathophysiology of stroke. Ann. Intern. Med. 110, 992-1000 (1989).
19. O'Neill, M.J. et al. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. Neuropharmacology 37, 1211-1222 (1998).
20. Rosenberg, L.J., Teng, Y.D., Wrathall, J. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J. Neurosci. 19, 464-475 (1999).
21. Espey, M.G., Kustova, Y., Sei, Y. & Basile, A.S. Extracellular glutamate levels are chronically elevated in the brains of LP-BM5-infected mice: a mechanism of retrovirus-induced encephalopathy. J. Neurochem. 71, 2079-2087 (1998).
22. Adams R.D. & Kubik C.S. The morbid anatomy of the demyelinative diseases. Am. J. Med. 12, 510-518 (1952).